Filter

Refine by Subjects

Refine by Access

Refine by Type

Refine by Date

—
  • Print
  • Save

Browse

You are looking at 251 - 300 of 1,314 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

PART I BASIC CONCEPTS AND TEST INTERPRETATIONS

Christopher J. Edwards and Brian L. Erstad

Chapter

Cover
Published (Print):
01 Jan 2022
Restricted access
Cover Basic Skills in Interpreting Laboratory Data

Basic Skills in Interpreting Laboratory Data

Christopher J. Edwards and Brian L. Erstad

Book

Published (Print):
01 Jan 2022
Restricted access

Benazepril Hydrochloride Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Bethanechol Chloride Solution 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Bethanechol Chloride Suspension 5 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Buspirone Hydrochloride Syrup 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Busulfan Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Caffeine Citrate Solution 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

21 Cancers and Tumor Markers

Sarah A. Schmidt

Chapter

Cover Basic Skills in Interpreting Laboratory Data

In  Basic Skills in Interpreting Laboratory Data

Published (Print):
01 Jan 2022
Restricted access

Candesartan Cilexetil Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Captopril Solution 1 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Captopril Suspension 0.75 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Captopril Suspension 0.8 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Captopril Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

CH 2.6 Carbamazepine

John E. Murphy

Chapter

Cover Clinical Pharmacokinetics Workbook

In  Clinical Pharmacokinetics Workbook

Published (Print):
01 Jan 2022
Restricted access

CH 1.6 Carbamazepine

John E. Murphy

Chapter

Cover Clinical Pharmacokinetics Workbook

In  Clinical Pharmacokinetics Workbook

Published (Print):
01 Jan 2022
Restricted access

12 CARBAMAZEPINE

Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin

Chapter

Cover Clinical Pharmacokinetics

In  Clinical Pharmacokinetics

Published (Print):
01 Jan 2022
Restricted access

Carbamazepine Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Carbamazepine Syrup 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

7 Cardiac Function and Related Tests

Jessica DeAngelo and Jacqueline Finger

Chapter

Cover Basic Skills in Interpreting Laboratory Data

In  Basic Skills in Interpreting Laboratory Data

Published (Print):
01 Jan 2022
Restricted access

Carvedilol Suspension 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Carvedilol Suspension 1.67 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Carvedilol Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cefazolin Sodium Ophthalmic Solution 33 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Celecoxib Suspension 10 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Celecoxib Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Chloroquine Phosphate Suspension 15 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Chloroquine Phosphate Suspension 15 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Chloroquine Phosphate Syrup 16.7 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Chlorpromazine Hydrochloride Syrup 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cholecalciferol Suspension 50,000 units/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cidofovir Intravitreous Solution 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cidofovir Intravitreous Solution 8.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cinacalcet Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Ciprofloxacin Hydrochloride Suspension 50 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Ciprofloxacin Hydrochloride Suspension 50 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access
Cover Clinical Pharmacokinetics

Clinical Pharmacokinetics

John E. Murphy

Book

Published (Print):
01 Jan 2022
Restricted access
Cover Clinical Pharmacokinetics Workbook

Clinical Pharmacokinetics Workbook

John E. Murphy

Book

Published (Print):
01 Jan 2022
Restricted access

Clonazepam Suspension 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Clonazepam Suspension 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Clonidine Hydrochloride Suspension 0.01 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Clonidine Hydrochloride Syrup 0.02 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Clonidine Hydrochloride Syrup 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Clopidogrel Bisulfate Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Codeine Phosphate Syrup 3 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Commercially Available Products (Use Only if Commercially Unavailable)

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover
Published (Print):
Jan 2022
Restricted access

7 CONSIDERATIONS FOR MEDICATION USE IN THE GERIATRIC PATIENT

Susan W. Miller

Chapter

Cover Clinical Pharmacokinetics

In  Clinical Pharmacokinetics

Published (Print):
01 Jan 2022
Restricted access

Cyclophosphamide Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Cyclosporine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Dantrolene Sodium Syrup 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022